Albert Dorr

1.0k total citations
27 papers, 783 citations indexed

About

Albert Dorr is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Albert Dorr has authored 27 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 12 papers in Epidemiology and 11 papers in Infectious Diseases. Recurrent topics in Albert Dorr's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (10 papers) and Influenza Virus Research Studies (5 papers). Albert Dorr is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (10 papers) and Influenza Virus Research Studies (5 papers). Albert Dorr collaborates with scholars based in United States, United Kingdom and Switzerland. Albert Dorr's co-authors include Donald Jung, Penelope Ward, Kare Gundersen, John C. Schneider, Charles Oo, Keith Nieforth, George Hill, Stanley J. Kolis, Joanne Barrett and Baolian Liu and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Dairy Science and International Journal of Pharmaceutics.

In The Last Decade

Albert Dorr

27 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Dorr United States 15 348 194 130 122 121 27 783
Bertrand Diquet France 18 123 0.4× 153 0.8× 264 2.0× 108 0.9× 58 0.5× 52 1.0k
Emmanuel Chigutsa United States 15 237 0.7× 526 2.7× 94 0.7× 73 0.6× 119 1.0× 28 857
Celestine N. Wanjalla United States 16 217 0.6× 268 1.4× 180 1.4× 221 1.8× 47 0.4× 60 936
Robert R. LaBadie United States 21 139 0.4× 211 1.1× 234 1.8× 33 0.3× 58 0.5× 51 1.0k
Judit Morelló Portugal 20 331 1.0× 561 2.9× 153 1.2× 285 2.3× 33 0.3× 55 1.1k
Susan D. Rouster United States 23 1.5k 4.2× 584 3.0× 135 1.0× 182 1.5× 45 0.4× 70 2.2k
Verónica Franco United States 16 96 0.3× 78 0.4× 98 0.8× 63 0.5× 116 1.0× 59 880
George Stepan United States 14 181 0.5× 445 2.3× 299 2.3× 281 2.3× 25 0.2× 22 1.0k
Keith Nieforth United States 16 249 0.7× 214 1.1× 137 1.1× 120 1.0× 51 0.4× 31 792
Belle L. Lee United States 12 215 0.6× 438 2.3× 112 0.9× 204 1.7× 25 0.2× 15 835

Countries citing papers authored by Albert Dorr

Since Specialization
Citations

This map shows the geographic impact of Albert Dorr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Dorr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Dorr more than expected).

Fields of papers citing papers by Albert Dorr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Dorr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Dorr. The network helps show where Albert Dorr may publish in the future.

Co-authorship network of co-authors of Albert Dorr

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Dorr. A scholar is included among the top collaborators of Albert Dorr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Dorr. Albert Dorr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ruxrungtham, Kiat, Mark Boyd, S. Eralp Bellibas, et al.. (2004). Lack of Interaction between Enfuvirtide and Ritonavir or Ritonavir‐Boosted Saquinavir in HIV‐1‐Infected Patients. The Journal of Clinical Pharmacology. 44(7). 793–802. 20 indexed citations
4.
Bellibas, S. Eralp, Albert Dorr, A Bertasso, et al.. (2004). Pharmacokinetics of Enfuvirtide in Pediatric Human Immunodeficiency Virus 1-Infected Patients Receiving Combination Therapy. The Pediatric Infectious Disease Journal. 23(12). 1137–1141. 20 indexed citations
5.
Oo, Charles, et al.. (2003). Pharmacokinetics and delivery of the anti-influenza prodrug oseltamivir to the small intestine and colon using site-specific delivery capsules. International Journal of Pharmaceutics. 257(1-2). 297–299. 22 indexed citations
6.
Boyd, Mark, Xiaoping Zhang, Albert Dorr, et al.. (2003). Lack of Enzyme‐Inducing Effect of Rifampicin on the Pharmacokinetics of Enfuvirtide. The Journal of Clinical Pharmacology. 43(12). 1382–1391. 35 indexed citations
7.
Oo, Charles, George Hill, Albert Dorr, et al.. (2003). Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1?5�years. European Journal of Clinical Pharmacology. 59(5-6). 411–415. 52 indexed citations
8.
Oo, Charles, Joanne Barrett, Albert Dorr, Baolian Liu, & Penelope Ward. (2002). Lack of Pharmacokinetic Interaction between the Oral Anti-Influenza Prodrug Oseltamivir and Aspirin. Antimicrobial Agents and Chemotherapy. 46(6). 1993–1995. 20 indexed citations
9.
Reuter, Martin, et al.. (2002). The role of cortisol suppression on craving for and satisfaction from nicotine in high and low impulsive subjects. Human Psychopharmacology Clinical and Experimental. 17(5). 213–224. 28 indexed citations
10.
Zhang, Xiaoping, Keith Nieforth, Régine Rouzier‐Panis, et al.. (2002). Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patientswith human immunodeficiency virus: Inverse Gaussian density absorption and 2‐compartment disposition*. Clinical Pharmacology & Therapeutics. 72(1). 10–19. 52 indexed citations
11.
Oo, Charles, Joanne Barrett, George Hill, et al.. (2001). Pharmacokinetics and Dosage Recommendations for an Oseltamivir Oral Suspension for the Treatment of Influenza in Children. Pediatric Drugs. 3(3). 229–236. 67 indexed citations
12.
Dorr, Albert, et al.. (2000). The Comparative Pharmacokinetics and Safety of the Oral Neuraminidase Inhibitor Oseltamivir when Given in Multiple Doses to Healthy Japanese and Caucasian Subjects.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 31(2). 397–398. 1 indexed citations
13.
Massarella, Joseph, et al.. (2000). The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64–0796/GS4104) in Healthy Adult and Elderly Volunteers. The Journal of Clinical Pharmacology. 40(8). 836–843. 73 indexed citations
14.
Jung, Donald, et al.. (1999). The pharmacokinetics and safety profile of oral ganciclovir in combination with trimethoprim in HIV‐ and CMV‐seropositive patients. British Journal of Clinical Pharmacology. 47(3). 255–259. 5 indexed citations
15.
Jung, Donald & Albert Dorr. (1999). Single‐Dose Pharmacokinetics of Valganciclovir in HIV‐ and CMV‐Seropositive Subjects. The Journal of Clinical Pharmacology. 39(8). 800–804. 120 indexed citations
16.
Jung, Donald, et al.. (1999). Effect of Food on High‐Dose Oral Ganciclovir Disposition in HIV‐Positive Subjects. The Journal of Clinical Pharmacology. 39(2). 161–165. 2 indexed citations
17.
Jung, Donald, et al.. (1999). The Pharmacokinetics and Safety Profile of Oral Ganciclovir Combined with Zalcitabine or Stavudine in Asymptomatic HIV‐ and CMV‐Seropositive Patients. The Journal of Clinical Pharmacology. 39(5). 505–512. 3 indexed citations
18.
Jung, Donald, Albert Dorr, Robert Raschke, et al.. (1998). Effect of High‐Dose Oral Ganciclovir on Didanosine Disposition in Human Immunodeficiency Virus (HIV)‐Positive Patients. The Journal of Clinical Pharmacology. 38(11). 1057–1062. 15 indexed citations
19.
Lavelle, James P., Stephen Follansbee, Carol Braun Trapnell, et al.. (1996). Effect of Food on the Relative Bioavailability of Oral Ganciclovir. The Journal of Clinical Pharmacology. 36(3). 238–241. 22 indexed citations
20.
Edgren, Richard A., Donald Jung, Edward J. Mroszczak, et al.. (1989). Pharmacokinetics of norethindrone: Effect of particle size. Contraception. 40(6). 731–740. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bertrand Diquet Breakdown of academic impact, for papers by Emmanuel Chigutsa Breakdown of academic impact, for papers by Celestine N. Wanjalla Breakdown of academic impact, for papers by Robert R. LaBadie Breakdown of academic impact, for papers by Judit Morelló Breakdown of academic impact, for papers by Susan D. Rouster Breakdown of academic impact, for papers by Verónica Franco Breakdown of academic impact, for papers by George Stepan Breakdown of academic impact, for papers by Keith Nieforth Breakdown of academic impact, for papers by Belle L. Lee
Rankless by CCL
2026